Candida auris: A Quick Review on Identification, Current Treatments, and Challenges
- PMID: 33922907
- PMCID: PMC8123192
- DOI: 10.3390/ijms22094470
Candida auris: A Quick Review on Identification, Current Treatments, and Challenges
Abstract
Candida auris is a novel and major fungal pathogen that has triggered several outbreaks in the last decade. The few drugs available to treat fungal diseases, the fact that this yeast has a high rate of multidrug resistance and the occurrence of misleading identifications, and the ability of forming biofilms (naturally more resistant to drugs) has made treatments of C. auris infections highly difficult. This review intends to quickly illustrate the main issues in C. auris identification, available treatments and the associated mechanisms of resistance, and the novel and alternative treatment and drugs (natural and synthetic) that have been recently reported.
Keywords: Candida auris; antifungal; biofilm; infection; novel therapy; resistance.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
Candida auris: A pathogen difficult to identify, treat, and eradicate and its characteristics in Japanese strains.J Infect Chemother. 2019 Oct;25(10):743-749. doi: 10.1016/j.jiac.2019.05.034. Epub 2019 Jun 28. J Infect Chemother. 2019. PMID: 31257156 Review.
-
Candida auris: a comparison between planktonic and biofilm susceptibility to antifungal drugs.J Med Microbiol. 2019 Sep;68(9):1353-1358. doi: 10.1099/jmm.0.001036. Epub 2019 Jul 4. J Med Microbiol. 2019. PMID: 31271350
-
A decade after the emergence of Candida auris: what do we know?Eur J Clin Microbiol Infect Dis. 2020 Sep;39(9):1617-1627. doi: 10.1007/s10096-020-03886-9. Epub 2020 Apr 15. Eur J Clin Microbiol Infect Dis. 2020. PMID: 32297040 Review.
-
A multicentre study of antifungal susceptibility patterns among 350 Candida auris isolates (2009-17) in India: role of the ERG11 and FKS1 genes in azole and echinocandin resistance.J Antimicrob Chemother. 2018 Apr 1;73(4):891-899. doi: 10.1093/jac/dkx480. J Antimicrob Chemother. 2018. PMID: 29325167
-
Understanding Echinocandin Resistance in the Emerging Pathogen Candida auris.Antimicrob Agents Chemother. 2018 May 25;62(6):e00238-18. doi: 10.1128/AAC.00238-18. Print 2018 Jun. Antimicrob Agents Chemother. 2018. PMID: 29632013 Free PMC article.
Cited by
-
Exploring the biomedical potential of a novel modified glass ionomer cement against the pandrug-resistant oral pathogen Candida albicans SYN-01.J Oral Microbiol. 2023 Mar 30;15(1):2195741. doi: 10.1080/20002297.2023.2195741. eCollection 2023. J Oral Microbiol. 2023. PMID: 37008537 Free PMC article.
-
Marine Compounds with Anti-Candida sp. Activity: A Promised "Land" for New Antifungals.J Fungi (Basel). 2022 Jun 25;8(7):669. doi: 10.3390/jof8070669. J Fungi (Basel). 2022. PMID: 35887426 Free PMC article. Review.
-
Candida Cell-Surface-Specific Monoclonal Antibodies Protect Mice against Candida auris Invasive Infection.Int J Mol Sci. 2021 Jun 7;22(11):6162. doi: 10.3390/ijms22116162. Int J Mol Sci. 2021. PMID: 34200478 Free PMC article.
-
A clinical and molecular analysis of Candidozyma auris strains from Romania, 2022-2023.Microbiol Spectr. 2025 Jul;13(7):e0280924. doi: 10.1128/spectrum.02809-24. Epub 2025 May 19. Microbiol Spectr. 2025. PMID: 40387391 Free PMC article.
-
Therapeutic Intervention for Various Hospital Setting Strains of Biofilm Forming Candida auris with Multiple Drug Resistance Mutations Using Nanomaterial Ag-Silicalite-1 Zeolite.Pharmaceutics. 2022 Oct 21;14(10):2251. doi: 10.3390/pharmaceutics14102251. Pharmaceutics. 2022. PMID: 36297684 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical